Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001171843-16-010367
Filing Date
2016-05-27
Accepted
2016-05-27 17:07:55
Documents
2
Period of Report
2016-05-25

Document Format Files

Seq Description Document Type Size
1 formfour.html 4  
1 formfour.xml 4 7475
2 POWER OF ATTORNEY exh_241.htm EX-24 4963
  Complete submission text file 0001171843-16-010367.txt   13786
Mailing Address C/O ASPREVA PHARMACEUTICALS CORPORATION 1203-4464 MARKHAM STREET VICTORIA A1 V8Z 7X8
Business Address
Hayden Michael R (Reporting) CIK: 0001352908 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36687 | Film No.: 161683194

Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Issuer) CIK: 0001582313 (see all company filings)

EIN.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations